BNGO Annual Current Liabilities
$100.03 M
+$64.14 M+178.75%
31 December 2023
Summary:
As of January 22, 2025, BNGO annual total current liabilities is $100.03 million, with the most recent change of +$64.14 million (+178.75%) on December 31, 2023. During the last 3 years, it has risen by +$91.08 million (+1018.26%). BNGO annual current liabilities is now at all-time high.BNGO Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BNGO Quarterly Current Liabilities
$32.95 M
-$4.22 M-11.37%
01 September 2024
Summary:
As of January 22, 2025, BNGO quarterly total current liabilities is $32.95 million, with the most recent change of -$4.22 million (-11.37%) on September 1, 2024. Over the past year, it has dropped by -$4.22 million (-11.37%). BNGO quarterly current liabilities is now -67.06% below its all-time high of $100.03 million, reached on December 31, 2023.BNGO Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BNGO Current Liabilities Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +178.8% | -11.4% |
3 y3 years | +1018.3% | +86.1% |
5 y5 years | +2111.6% | +343.0% |
BNGO Current Liabilities High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +358.0% | -67.1% | +76.6% |
5 y | 5-year | at high | +1018.3% | -67.1% | +359.6% |
alltime | all time | at high | +2111.6% | -67.1% | +628.5% |
Bionano Genomics Current Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $32.95 M(-11.4%) |
June 2024 | - | $37.17 M(-36.5%) |
Mar 2024 | - | $58.51 M(-41.5%) |
Dec 2023 | $100.03 M(+178.8%) | $100.03 M(+148.9%) |
Sept 2023 | - | $40.19 M(+20.0%) |
June 2023 | - | $33.50 M(-12.2%) |
Mar 2023 | - | $38.13 M(+6.3%) |
Dec 2022 | $35.88 M(+64.3%) | $35.88 M(+7.1%) |
Sept 2022 | - | $33.50 M(+20.0%) |
June 2022 | - | $27.91 M(+49.6%) |
Mar 2022 | - | $18.66 M(-14.6%) |
Dec 2021 | $21.84 M | $21.84 M(+23.4%) |
Sept 2021 | - | $17.70 M(+65.0%) |
June 2021 | - | $10.73 M(+49.7%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2021 | - | $7.17 M(-19.9%) |
Dec 2020 | $8.95 M(-66.1%) | $8.95 M(-63.9%) |
Sept 2020 | - | $24.78 M(+27.0%) |
June 2020 | - | $19.51 M(-15.9%) |
Mar 2020 | - | $23.19 M(-12.1%) |
Dec 2019 | $26.37 M(+483.0%) | $26.37 M(+254.5%) |
Sept 2019 | - | $7.44 M(-1.4%) |
June 2019 | - | $7.54 M(+60.0%) |
Mar 2019 | - | $4.71 M(+4.2%) |
Dec 2018 | $4.52 M(-72.8%) | $4.52 M(-18.0%) |
Sept 2018 | - | $5.51 M(-75.4%) |
June 2018 | - | $22.43 M(-16.5%) |
Mar 2018 | - | $26.85 M(+61.3%) |
Dec 2017 | $16.65 M(+77.8%) | $16.65 M |
Dec 2016 | $9.36 M | - |
FAQ
- What is Bionano Genomics annual total current liabilities?
- What is the all time high annual current liabilities for Bionano Genomics?
- What is Bionano Genomics annual current liabilities year-on-year change?
- What is Bionano Genomics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Bionano Genomics?
- What is Bionano Genomics quarterly current liabilities year-on-year change?
What is Bionano Genomics annual total current liabilities?
The current annual current liabilities of BNGO is $100.03 M
What is the all time high annual current liabilities for Bionano Genomics?
Bionano Genomics all-time high annual total current liabilities is $100.03 M
What is Bionano Genomics annual current liabilities year-on-year change?
Over the past year, BNGO annual total current liabilities has changed by +$64.14 M (+178.75%)
What is Bionano Genomics quarterly total current liabilities?
The current quarterly current liabilities of BNGO is $32.95 M
What is the all time high quarterly current liabilities for Bionano Genomics?
Bionano Genomics all-time high quarterly total current liabilities is $100.03 M
What is Bionano Genomics quarterly current liabilities year-on-year change?
Over the past year, BNGO quarterly total current liabilities has changed by -$4.22 M (-11.37%)